Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65

Robert Buynak,Kevin Cannon, David DeAtkine, John Kirby,Lisa Usdan,Amit Bhavsar, Catherine Gérard,Anastasia Kuznetsova, Amulya Jayadev,Hiwot Amare, Sofia Valenciano,Nadia Meyer

Infectious Diseases and Therapy（2024）

引用 1|浏览9

关键词

High-dose,quadrivalent influenza vaccine (FLU-QIV-HD),Immunogenicity,Older adults,Randomized controlled trial,Reactogenicity,Respiratory syncytial virus (RSV),RSV prefusion protein F3 older adult (RSVPreF3 OA) vaccine,Safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要